web analytics
July 30, 2014 / 3 Av, 5774
Israel at War: Operation Protective Edge
 
 

Posts Tagged ‘pharmaceuticals’

Israel Start-Up’s Anti-Obesity Pill Set to Go Big Time

Monday, March 11th, 2013

The Israeli start-up Gelesis is in advanced talks with a large pharmaceutical company to develop its pill that makes fat people feel their stomachs are full, resulting in less food intake and a loss in weight.

The pharma company was not identified by Israel’s Globes business newspaper, which said that Gelesis soon will publish results of a recent clinical trial of the pill.

Instead of asking the US Food and Drug Administration (FDA) to consider the product as a nutritional supplement or medical device, the Israeli company wants to offer it is a medicine to increase its market appeal.

The value of the deal with the foreign pharmaceutical company could reach hundreds of millions of dollars. The unidentified company will invest millions of dollars for developing the pill and will pay royalties on sales, Globes added.

The slim-down pill is made from indigestible edible fiber taken before a meal. The pills, after coming in contact with water, inflate and  make food more viscous, keeping it in the stomach longer, and creating the sense of being sated.

A study of the pill’s effects several years ago showed a high rate of those who said they felt they had enough to eat, while only 16 percent reported they suffered side effects of discomfort, which Gelesis may be able to reduce by changing the dosage for certain individuals.

Obesity is a leading cause of death, and the leading treatment for obesity is through surgery.

The obesity treatment market currently includes various appetite suppressants, but the leading solution for morbid obesity is stomach bypass or reduction surgery. Although other products for filling the stomach are under development, Gelesis’ edge is that its product works with food.

A small number of diet drugs are on the market or are being studied by the FDA, but their success has been limited.

Besides Gelesis, at least one other company, EntroMedics, has developed a system to limit the expansion of the stomach and control hunger sensations. However, clinical trials last month were disappointing.

Israeli Pharmaceutical Sales Certified in Europe

Wednesday, October 24th, 2012

The European Parliament has approved a pharmaceutical trade agreement with Israel after two years of attempts by the Palestinian Solidarity Campaign to block the partnership.

The Agreement on Conformity Assessment and Acceptance of Industrial Products (ACAA), simplifying sales of Israeli pharmaceuticals in the European Union, passed Tuesday by 379-230.

The measure recognizes Israeli pharmaceutical standards as equal to those of Europe.  It was approved by the European council in March 2010, but its implementation was thwarted by pro-Palestinian organizations who sought to foil Israel’s entry into the European market.

Teva Opens Massive Plant in Hungary

Monday, October 15th, 2012

Teva Pharmaceuticals has opened a new $110 million plant in Hungary, set to be one of the largest sterile medicines plants in the world.

The 15,000 square meter plant will work primarily in oncology therapeutics, and will produce 160-200 million units of injectables a year.

Teva has been operating in Hungary since 1993, operating a tablet production facility, an advanced pharmaceutical ingredients manufacturing plant, and now the sterile plant, and employs 3,5000 Hungarians.

Printed from: http://www.jewishpress.com/news/teva-opens-massive-plant-in-hungary/2012/10/15/

Scan this QR code to visit this page online: